Medical Research News

RSS

Comprehensive Wastewater Genomics Detects All Oncogenic Viruses Concurrently

A study published in Applied and Environmental Microbiology is the first comprehensive approach to detect all known cancer-causing or oncogenic viruses concurrently by analyzing viral genomes in wastewater.

15 May 2026

Restricted Interaction Peptides Change Shape to Lock Therapy Inside Solid Tumors

Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target.

14 May 2026

A Possible Brain Fluid Recycling System In Humans

A study shows cerebrospinal fluid circulates in the brain, enhancing waste clearance and offering insights into aging and neurodegenerative disease mechanisms.

14 May 2026

Study Reveals New Biological Pathway for TNF-Resistant Crohn’s Disease

Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.

14 May 2026

Phesi Analysis of More Than 600,000 Clinical Trial Protocols Finds Less Than a Third are Linked to Patient Data

Phesi, a global provider of patient-centric data science solutions for clinical development, has conducted a global analysis of more than 600,000 clinical trial protocols ahead of ASCO 2026.

From Phesi 13 May 2026

AI Eye Scan Detects Diabetes And Chronic Diseases In 30 Seconds

Reti-Pioneer is an AI system that analyzes retinal images for rapid detection of chronic diseases, enhancing early diagnosis and healthcare accessibility.

13 May 2026

Twisted Light Breakthrough Could Enable Earlier Disease Detection

Researchers from the Australian Research Council Centre of Excellence in Optical Microcombs for Breakthrough Science (COMBS) have developed a powerful new way to use light to measure tiny changes in biological fluids such as blood – using samples as small as a millionth of a drop.

12 May 2026

Promising New Hanta Virus Vaccine Under Development by University of Bath Researchers

A highly promising vaccine for Hanta virus is being developed by researchers from the University of Bath. The team is led by Professor Asel Sartbaeva, Chemistry researcher at the University and co-founder of University spinout company Ensilitech.

8 May 2026

Why Women Face a Much Higher Risk of Autoimmune Disease

A recent study has identified biological abnormalities that make the female immune system more likely to mistakenly attack the body's own healthy tissues, providing insight into why women are significantly more likely than men to experience autoimmune diseases.

8 May 2026

How the Microbiome Shapes Cancer Immunity and Therapy Response

This review examines how the human microbiome regulates anti-tumor immunity through DNA damage, inflammation, immune-cell activity, microbial metabolites, and tumor microenvironment remodeling. It highlights emerging microbiome-based strategies, including FMT, probiotics, prebiotics, engineered bacteria, and live biotherapeutics, while stressing the need for rigorous validation and clinical trials.

29 Apr 2026

New Pistoia Alliance Poll Finds Regulatory Teams Benefit Most from AI, But Just 1 % See Value in the Wet Lab

The Pistoia Alliance, a global, not-for-profit that advocates for greater collaboration in life sciences R&D, has released new poll data from its annual European conference, revealing that while AI use is becoming widespread across life sciences organizations, its measurable impact on drug R&D remains limited.

From The Pistoia Alliance 29 Apr 2026

Genetic Study Reveals Biological Drivers of Frailty in Aging

Researchers at McMaster University have identified, for the first time, a novel region of DNA and two associated genes connected to frailty, offering neurological and immune-related insights that might help explain why some older adults are more likely to be frail than others.

22 Apr 2026

Researchers Develop 3D Organoids that Reflect the Complexity of Brain Tumors

Efforts to identify and evaluate next-generation therapeutics for pediatric brain tumors are easily stymied by the quality and availability of laboratory models for research. To address this issue, scientists at St. Jude Children's Research Hospital developed patient-derived tumor organoids and tumor organoid xenografts that accurately reflect the biologic underpinnings of embryonal brain tumors.

16 Apr 2026

New Genomic Data Confirms a Single Pathway for Esophageal Adenocarcinoma

Scientists have found the strongest evidence to date that a condition known as Barrett's esophagus is the starting point for all cases of esophageal adenocarcinoma – the most common type of esophageal cancer in the developed world – even when telltale signs of this pre-cancerous stage are no longer visible.

16 Apr 2026

Allied Vision Cameras Unlock Research that Could Transform How Cancer Patients Receive Radiotherapy

Allied Vision today announced that its exo183CGE CMOS camera served as the core imaging hardware in a peer-reviewed study on upright radiotherapy patient positioning, a medically critical discipline where millimeter-scale errors can carry clinical consequences.

From Allied Vision 15 Apr 2026

Semen-Derived Exosomes Eye Drops to Treat Retinoblastoma

Innovative eye drops using semen-derived exosomes target retinoblastoma, improving therapeutic delivery and preserving ocular function in preclinical models.

8 Apr 2026

Regenerative Vascular Grafts Solve Key Shortage In Surgery

Engineered biotubes demonstrate strong mechanical performance and rapid tissue regeneration, offering a scalable solution to the vascular graft shortage.

2 Apr 2026

A Python-Inspired Molecule Suppresses Appetite After Eating

The study identifies pTOS as a key metabolite in appetite suppression, highlighting a gut–liver–brain pathway with implications for obesity therapy.

2 Apr 2026

PRISM ALS: New Stem Cell Models Could Transform Research into Treatments for MND/ALS

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current cell models used for testing treatments do not currently reflect the diverse nature of the disease – that affects both researchers developing therapies and the people urgently waiting for them.

From Axol Bioscience Ltd 2 Apr 2026

Excessive RNA Editing May Explain Neurological Differences in Down Syndrome

A collaborative research study co-led by scientists at the Icahn School of Medicine at Mount Sinai and the Liber Institute for Brain Development has for the first time identified a biological process that may help explain how the brain develops differently in people with Down syndrome. The study was a collaboration among scientists from the Icahn School of Medicine at Mount Sinai, the Lieber Institute for Brain Development, the Medical University of Sofia in Bulgaria, and the University of Arizona.

2 Apr 2026